Log In
BCIQ
Print this Print this
 

LY3016859

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionAnti-TGF-alpha/epiregulin antibody
Molecular Target Transforming growth factor (TGF) alpha (TGFA) ; Epiregulin (EREG)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard Indication Renal (unspecified)
Indication DetailsTreat chronic kidney disease (CKD) associated with diabetic nephropathy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today